Wisconsin Alumni Research Foundation

Technology

Antifungal Compounds

Compounds of formula (I) or formula (II), compositions and methods useful for treating and/or preventing a fungal infections are provided. wherein the substituents are as defined in the appended claim...
Learn More
Cameron Currie, Ethan Van Amam, Clarissa Sit, Antonio Ruzzini, Jon Clardy, Adrian Pinto-Tomas | P170089US03

Technology

Cyphomycin, Compositions And Uses Thereof

Cyphomycin, an isolated compound of Formula I or IA is provided. A compound isolated from insect Streptomyces and having a chemical formula of C77H122O26 is also provided. Compositions including Cypho...
Learn More
Cameron Currie, Timothy Bugni, Monica Pupo, David Andes, Humberto Ortega Dominguez | P180334US02

Technology

Humanized Cell Line

A mammalian or avian cell line that expresses high levels of human influenza virus receptors is provided. In one embodiment, the cell line supports human influenza virus, e.g., human A/H3 influenza vi...
Learn More
Yoshihiro Kawaoka, Kosuke Takada, Masaki Imai | P180301US03

Technology

Novel Adjuvant For Animal And Human Vaccines

Quil-A chitosan spherical nanostructure complexes as well as methods of making and using such complexes are disclosed herein. Also provided are Quil-A chitosan spherical nanostrucutres loaded with one...
Learn More
Adel Talaat, Shaswath Chandrasekar | P190189US02

Technology

Compositions And Methods For The Inhibition Of Fibrosis

Described herein is a mono-end PEGyated functional upstream domain (FUD), pharmaceutical compositions, and its use to inhibit fibrosis such as organ fibrosis, idiopathic pulmonary fibrosis and fibrosi...
Learn More
Bianca Tomasini-Johansson, Glen Kwon, Pawel Zbyszynski, Nathan Sandbo, Ksenija Bernau | P180076US02

WARF